Impact of a Biophoton Therapy on Patients With Brain Disorders
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Parkinson's disease. The current study is to confirm the previous clinical observation by conducting as a randomized, triple-blinded, placebo-controlled prospective intervention clinical research. About 80 patients with brain disorder (Alzheimer's disease, dementia, stroke, traumatic brain injury, Parkinson's disease) will participate in the intervention clinical study at the Tesla MedBed Center located in Butler, PA.
Sponsor: First Institute of All Medicines
You may qualify if…
- ✓ Must meet conditions for approval.
- ✓ Must be 18-years or older and stay in a hotel.
- ✓ Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
- ✓ Can provide informed consent or can be assisted by caregiver.
- ✓ Can provide a clinical diagnosis of a brain disorder.
- ✓ Can complete all study procedures during the study.
- ✓ Must be fluent in English (or the Caregiver can fully translate).
- ✓ Women of childbearing age must provide results of a pregnancy test in order to participate.
You may not qualify if…
- ✕ Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert.
- ✕ Someone that relies on a ventilator.
- ✕ Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices.
- ✕ Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis.
- ✕ Is participating in another investigational drug or device trial.
- ✕ Has an active infectious disease, such as COVID-19.
- ✕ Pregnant women.
Where it's recruiting
Butler
Source: ClinicalTrials.gov · NCT06147999 · last updated 2025-08-08